欧洲多中心研究中助听器缓解耳鸣症状的预测因素
研究纳入UNITI随机对照试验中仅接受助听器治疗的60例慢性耳鸣伴轻中度听力损失患者,助听器按NAL-NL2或DSL(i/o)v.5公式验配并原位验证,治疗12周。结果显示6周和12周时耳鸣困扰显著下降,但耳鸣响度未变,且耳鸣频率、听力损失程度、助听器使用时间和验配准确性均未预测疗效。
要点
- 助听器使用6周和12周时耳鸣困扰较基线显著下降,6至12周间无进一步显著下降。
- 主观耳鸣响度在治疗前后无显著变化。
- 耳鸣频率、听力损失程度、助听器使用时间和验配准确性均未预测耳鸣困扰的改善。
核心结论
- 助听器使用与耳鸣相关困扰的降低有关,且不受耳鸣属性、听力损失程度或助听器验配特征的影响。
- 需要未来研究纳入更多预测因素、对照组和更大、更异质的样本来进一步阐明听力放大在听力损失伴慢性耳鸣个体中的变化机制。
研究设计与样本
- 研究为欧洲五个研究中心开展的大型多中心随机对照试验UNITI的一部分,报告随机分配至仅助听器治疗组的60例慢性耳鸣伴轻中度听力损失参与者。
- 助听器按国家声学实验室-非线性2(NAL-NL2)或期望感觉水平(DSL)(i/o)v.5验配公式编程,并使用原位验证确认验配。
- 参与者接受为期12周的治疗阶段,在治疗6周和12周后评估耳鸣困扰(THI和TFI)及主观耳鸣响度(dB HL)。
- 助听器验配准确性操作化为原位测量的真耳助听响应与相应验配公式规定的目标真耳助听响应参数的偏差。
主要发现
- 参与者在12周治疗阶段内助听器使用时间平均为4.8小时/天(标准差2.4小时/天)。
- 多级回归分析显示,与基线相比,治疗6周和12周后耳鸣困扰评分显著降低(THI:F(2,156)=7.80,p<0.01;TFI:F(2,155)=8.79,p<0.01)。
- 助听器使用6周后,THI评分平均降低11.64分,TFI评分平均降低12.80分。
- 助听器使用6至12周之间,耳鸣困扰无进一步统计学显著降低(THI:M=1.75,p=0.89;TFI:M=-1.58,p=0.91)。
- 主观耳鸣响度在治疗前后保持不变(M=1.90;F(1,105)=0.40,p=0.53)。
关键数值与推荐
- 耳鸣困扰采用耳鸣残疾量表(THI)和耳鸣功能指数(TFI)评估,主观耳鸣响度以dB HL评估。
- 助听器验配公式为国家声学实验室-非线性2(NAL-NL2)或期望感觉水平(DSL)(i/o)v.5,验配通过原位验证确认。
临床怎么用
- 原文未据此给出推荐。
- 作者在结论中指出,助听器使用与耳鸣相关困扰的降低有关,且不受耳鸣属性、听力损失程度或助听器验配特征的影响。
- 作者认为需要未来研究纳入更多预测因素、对照组和更大、更异质的样本来进一步阐明机制。
局限性
- 作者指出需要未来研究纳入更多预测因素、对照组和更大、更异质的样本来进一步阐明听力放大在听力损失伴慢性耳鸣个体中的变化机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Hearing aids (HAs) are a widely accepted first-line treatment option for individuals suffering from both hearing loss and chronic tinnitus. Though HAs are highly effective at improving speech understanding, their effectiveness in ameliorating tinnitus symptoms is less clear. In recent years, several investigators have reported on attempts to predict HAs effectiveness on tinnitus symptoms using an array of variables. These included tinnitus attributes (e.g., frequency, loudness, character), audiological characteristics (e.g., degree and configuration of hearing loss), or HA signal processing parameters (e.g., gain, noise reduction processing). The aims of this study were to determine whether (1) HA usage improves tinnitus-related distress and subjective tinnitus loudness and, if so, whether (2) tinnitus frequency, degree of hearing loss, HA-use time, and the accuracy of the HA fitting influence this effect. DESIGN: Participants were recruited as part of the "Unification of Treatments and Interventions for Tinnitus Patients (UNITI)" study, a large multicenter randomized controlled trial conducted across five European study sites. Here, we report on the 60 participants with chronic tinnitus and mild-to-moderate hearing loss that were randomized to the HAs-only treatment arm of UNITI. HAs were programmed according to the National Acoustic Laboratories-Nonlinear 2 or Desired Sensation Level ((i/o) v.5) prescriptive formulas and the fitting was verified using in-situ verification. Subsequently, participants underwent a 12-week treatment phase. Improvements in tinnitus-related distress measured with the Tinnitus Handicap Inventory (THI) and the Tinnitus Functional Index (TFI), as well as subjective tinnitus loudness (dB HL), were assessed after 6 and 12 weeks of treatment. Accuracy of the HA fitting was operationalized as the deviation of in-situ measured real ear-aided response from target real ear-aided response parameters, as specified by the respective prescriptive formula. RESULTS: Participants' HA-use time averaged 4.8 hr/d (SD 2.4 hr/d) over the 12-week treatment phase. Multilevel regression analyses revealed significant reductions of tinnitus distress scores after 6 and 12 weeks (THI: F (2,156) = 7.80, p < 0.01; TFI: F (2,155) = 8.79, p < 0.01) of treatment, as compared with baseline. After 6 weeks of HA usage, THI scores were decreased by 11.64 points and TFI scores by 12.80 points, on average. There was no further statistically significant reduction in tinnitus distress between 6 and 12 weeks of HA usage (THI: M = 1.75, p = 0.89; TFI: M = -1.58, p = 0.91). Contrary to expectations, none of the included factors predicted these effects. Subjective tinnitus loudness remained unchanged with treatment (M = 1.90; F (1,105) = 0.40, p = 0.53). CONCLUSIONS: HA usage is associated with reductions in tinnitus-related distress-irrespective of tinnitus attributes, degree of hearing loss, or HA fitting characteristics. Future research designs that include additional predictors, control groups and larger, more heterogeneous samples are needed to further clarify mechanisms of change with hearing amplification in individuals with hearing loss and chronic tinnitus.
引用
- Schiele T, Boecking B, Nyamaa A, et al. Predictors of Tinnitus Symptom Relief With Hearing Aids in a European Multicenter Study. Ear Hear. 2025. PMID: 39748158. doi:10.1097/AUD.0000000000001624
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。